Paper32284875
Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis.
Blindenbacher N and 12 others. Mult Scler J Exp Transl Clin, 2020. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis. Papers, record 32284875. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32284875
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29515576 | Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions. | Front Immunol | 2018 | https://conductscience.org/library/papers/29515576 | PubMed |
| 2 | 28408633 | Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis. | AJNR Am J Neuroradiol | 2017 | https://conductscience.org/library/papers/28408633 | PubMed |
| 3 | 27365331 | Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection. | AJNR Am J Neuroradiol | 2016 | https://conductscience.org/library/papers/27365331 | PubMed |
| 4 | 26800367 | Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM). | J Magn Reson Imaging | 2016 | https://conductscience.org/library/papers/26800367 | PubMed |
| 5 | 20625086 | Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. | Arch Neurol | 2010 | https://conductscience.org/library/papers/20625086 | PubMed |
| 6 | 26939635 | Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity. | AJNR Am J Neuroradiol | 2016 | https://conductscience.org/library/papers/26939635 | PubMed |
| 7 | 12482100 | Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. | Neuroimage | 2002 | https://conductscience.org/library/papers/12482100 | PubMed |
| 8 | 23868451 | Iron and neurodegeneration in the multiple sclerosis brain. | Ann Neurol | 2013 | https://conductscience.org/library/papers/23868451 | PubMed |
| 9 | 22641301 | A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis. | Mult Scler | 2013 | https://conductscience.org/library/papers/22641301 | PubMed |
| 10 | 22084205 | Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. | Radiology | 2012 | https://conductscience.org/library/papers/22084205 | PubMed |
| 11 | 27489865 | MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T. | Neurol Neuroimmunol Neuroinflamm | 2016 | https://conductscience.org/library/papers/27489865 | PubMed |
| 12 | 28332093 | Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/28332093 | PubMed |
| 13 | 23516409 | Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. | PLoS One | 2013 | https://conductscience.org/library/papers/23516409 | PubMed |
| 14 | 30212476 | Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging. | PLoS One | 2018 | https://conductscience.org/library/papers/30212476 | PubMed |
| 15 | 27256856 | Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation. | AJNR Am J Neuroradiol | 2016 | https://conductscience.org/library/papers/27256856 | PubMed |
| 16 | 25002107 | Iron in multiple sclerosis: roles in neurodegeneration and repair. | Nat Rev Neurol | 2014 | https://conductscience.org/library/papers/25002107 | PubMed |
| 17 | 25657078 | Heterogeneity of Multiple Sclerosis White Matter Lesions Detected With T2*-Weighted Imaging at 7.0 Tesla. | J Neuroimaging | 2015 | https://conductscience.org/library/papers/25657078 | PubMed |
| 18 | 27270171 | Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. | J Clin Invest | 2016 | https://conductscience.org/library/papers/27270171 | PubMed |
| 19 | 27796537 | Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/27796537 | PubMed |
| 20 | 21387374 | Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. | Ann Neurol | 2011 | https://conductscience.org/library/papers/21387374 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42623573 | The Prognostic Value of Paramagnetic Rim Lesions in People With Multiple Sclerosis. | Neurology | 2026 | https://conductscience.org/library/papers/42623573 | PubMed |
| 41989606 | Iron accumulation in multiple sclerosis and implications for cognitive and clinical progression: a systematic review of advanced neuroimaging studies. | J Neurol | 2026 | https://conductscience.org/library/papers/41989606 | PubMed |
| 41019415 | The presence of a paramagnetic phase rim in multiple sclerosis is linked to lesion age: An exploratory study. | Mult Scler J Exp Transl Clin | 2025 | https://conductscience.org/library/papers/41019415 | PubMed |
| 40357663 | Associations between chronic active lesions and clinical outcomes in multiple sclerosis: A systematic literature review. | J Manag Care Spec Pharm | 2025 | https://conductscience.org/library/papers/40357663 | PubMed |
| 40349257 | Clinical integration of brain and cord MRI features improves differential diagnosis of multiple sclerosis. | J Neurol | 2025 | https://conductscience.org/library/papers/40349257 | PubMed |
| 39819146 | Paramagnetic rim lesion formation is predicted by the initial gadolinium-enhancing lesion diameter. | Mult Scler | 2025 | https://conductscience.org/library/papers/39819146 | PubMed |
| 39812706 | Soma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis. | J Neurol | 2025 | https://conductscience.org/library/papers/39812706 | PubMed |
| 39711984 | Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance. | Ther Adv Neurol Disord | 2024 | https://conductscience.org/library/papers/39711984 | PubMed |
| 39224590 | A future of AI-driven personalized care for people with multiple sclerosis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39224590 | PubMed |
| 38942521 | New Imaging Markers in Multiple Sclerosis and Related Disorders: Smoldering Inflammation and the Central Vein Sign. | Neuroimaging Clin N Am | 2024 | https://conductscience.org/library/papers/38942521 | PubMed |
| 38366920 | Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years. | Mult Scler | 2024 | https://conductscience.org/library/papers/38366920 | PubMed |
| 38226694 | Imaging chronic active lesions in multiple sclerosis: a consensus statement. | Brain | 2024 | https://conductscience.org/library/papers/38226694 | PubMed |
| 38018353 | Paramagnetic rim lesions and the central vein sign: Characterizing multiple sclerosis imaging markers. | J Neuroimaging | 2024 | https://conductscience.org/library/papers/38018353 | PubMed |
| 37897254 | Susceptibility-based imaging aids accurate distinction of pediatric-onset MS from myelin oligodendrocyte glycoprotein antibody-associated disease. | Mult Scler | 2023 | https://conductscience.org/library/papers/37897254 | PubMed |
| 37792206 | Pediatric Multiple Sclerosis: Changing the Trajectory of Progression. | Curr Neurol Neurosci Rep | 2023 | https://conductscience.org/library/papers/37792206 | PubMed |
| 37719665 | Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China. | Ther Adv Neurol Disord | 2023 | https://conductscience.org/library/papers/37719665 | PubMed |
| 37712486 | Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis. | Mult Scler | 2023 | https://conductscience.org/library/papers/37712486 | PubMed |
| 36901807 | Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36901807 | PubMed |
| 36000485 | Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis. | Mult Scler | 2022 | https://conductscience.org/library/papers/36000485 | PubMed |
| 35865643 | Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis. | Front Neurol | 2022 | https://conductscience.org/library/papers/35865643 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD68 | 968 | PubTator's text mining | https://conductscience.org/library/genes/968 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32284875
GET https://conductscience.org/api/papers/v1/32284875/references?page=2